http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2402646-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cce74ae91129e276612f5855529149a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc33559526cf4b77411037911d198d9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4a936f1e0713980a2fae803df7b848a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53df2b154ebc0d94f4c42385d43a3bf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b345f338fbe6483ee0ec42b1b22ce45c
publicationDate 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2402646-A1
titleOfInvention USE OF A MELATONINE ANALOG FOR REDUCING INTRAOCULAR PRESSURE.
abstract Use of a melatonin analog for the reduction of intraocular pressure. Reduction of intraocular pressure by means of a melatonin analog. The present invention describes a method for reducing intraocular pressure by administering a pharmaceutical formulation of the commercial substance agomelatine, N- [2- (7-methoxynaphthalen-1-yl) ethyl] acetamide, and / or pharmaceutically acceptable salts. Of the same. The present invention also claims the use of agomelatine and / or pharmaceutically acceptable salts thereof for the preparation of a medicament for the treatment and / or prevention of hypertensive or normotensive glaucoma and / or diseases characterized by high intraocular pressure. Said medicament is preferably administered topically, vehiculized or not by liposomes, and can be presented in different pharmaceutical forms, such as solutions, suspensions, emulsions, eye drops, liquid drops, liquid washes, gels, creams, ointments, ointments and sprays .
priorityDate 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4543
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114211
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30660
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82148
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID244701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664

Total number of triples: 36.